Keywords: Depressive disorder, major; Treatment-resistant depression; Burden; Review; AD; Antidepressant; CBT; Cognitive behavioral therapy; CT; cognitive therapy; ECT; Electroconvulsive therapy; EQ-5D; EuroQol Five Dimension; HAM-D; Hamilton Depression Rating Scal
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: QALY; quality of life years; USDHHS; US Department of Health and Human Services; VSL; value per statistical life; Child maltreatment; Economic burden; Lifelong consequences;
Keywords: Cancer screening programmes; QALY; screening biases; screening criteria; screening test;
Keywords: Multiple sclerosis; Pharmaceutical reimbursement, Decision-making; CHMP; committee for medicinal for human use; ICER; incremental cost-effectiveness ratio; MCID; minimal clinically important difference; MS; multiple sclerosis; PBAC; pharmaceutical benefit
Keywords: 2; arthrodesis; cost; cost-effectiveness; foot and ankle surgery; Lisfranc; QALY; tarsometatarsal joint;
Keywords: AMD; age-related macular degeneration; QALY; quality-adjusted life-year;
Keywords: CABG; coronary artery bypass graft surgery; CI; confidence interval; MRSA; methicillin-resistant Staphylococcus aureus; MSSA; methicillin-susceptible Staphylococcus aureus; ND; no decolonization; QALY; quality-adjusted life-year; SSI; surgical site infect
Keywords: AUC; area under the curve; CE; cost effectiveness; CEAC; cost-effectiveness acceptability curve; CI; confidence interval; DMSIC; Drug and Medical Supply Information Center; DRG; diagnosis-related group; DSA; deterministic sensitivity analysis; EGFR; epide
Keywords: ASC; ambulatory surgical center; CPT; Current Procedural Terminology; PPV; pars plana vitrectomy; PVD; posterior vitreous detachment; QALY; quality-adjusted life year; RD; retinal detachment; SB; scleral buckle;
Keywords: prostatic neoplasms; United States Food and Drug Administration; patient preference; clinical decision making; equipment and supplies; AS; active surveillance; BOO; bladder outlet obstruction; FDA; Food and Drug Administration; HIFU; high intensity focuse
Keywords: 2; Achilles tendon; DVT; economic analysis; heparin; LMWH; QALY; venous thrombosis;
Keywords: disability; health disparities; heart failure; medical spending; ADL; activities of daily living; BMI; body mass index; CHF; congestive heart failure; CI; confidence interval; DFLY; disability-free life year; EQ-5D; EuroQol Five-Dimension Questionnaire; F
Keywords: abatacept; ACPA; adalimumab; cost effectiveness; economic model; ICER; QALY; rheumatoid arthritis; treatment costs;
Keywords: discrete choice experiments; EQ-5D; health preference research; QALY;
Keywords: Influenza; Cost-effectiveness; Vaccination; Trivalent; Quadrivalent; Dynamic transmission model; GDP; gross domestic product; ICER; incremental cost-effectiveness ratio; HIV; human immunodeficiency virus; IBS; individual based simulation; I$; internationa
Keywords: Helicobacter pylori; Neoplasm; Precancer; Preneoplasia; AG; atrophic gastritis; CRC; colorectal cancer; EGD; esophagogastroduodenoscopy; ESD; endoscopic submucosal dissection; GA; gastric adenocarcinoma; ICER; incremental cost-effectiveness ratio; IM; int
Keywords: ADA; American Diabetes Association; CI; Confidence interval; Finnish DPS; Finnish Diabetes Prevention Study; HR; Hazard ratio; IDPP-1; Indian Diabetes Prevention Programme; IFG; Impaired fasting glucose; IGT; Impaired glucose tolerance; QALY; Quality-adju
Keywords: Overactive bladder; Comparative effectiveness research; Patient-reported outcomes; Registry; Mirabegron; Antimuscarinic; AUA; American Urological Association; ENCePP; European Network of Centres for Pharmacoepidemiology and Pharmacovigilance; EQ-5Dâ¢; Eu
Keywords: DBD; donation after brain death; DCD; donation after cardiac death; OPC; organ procurement center; OPO; organ procurement organization; OR; operating room; QALY; quality-adjusted life year;
Keywords: Oral nutritional supplements; Dietary advice; Care home; Cost-effectiveness; QALY; ICER;
Keywords: CEAC; cost-effectiveness acceptability curves; CXR; chest x-ray; DW; disability weight; GBD; global burden of disease; GDP; gross domestic product; ICER; incremental cost effectiveness ratio; LDCT; low-dose computed tomography; NLST; National Lung Screeni
Keywords: Endometriosis; medical treatment; surgery; value of care; comparative cost-effectiveness research; burden of treatment; ART; assisted reproductive techniques; COI; conflict of interest; HRT; hormonal replacement therapy; NETA; norethindrone acetate; OC; o
Keywords: Advanced Liver Disease; Mortality; Portal Hypertension; Comparison; DRG; diagnosis-related group; HCUP; Healthcare Cost and Utilization Project; HE; hepatic encephalopathy; ICER; incremental cost-effectiveness ratio; LVP+A; serial large volume paracentesi
Keywords: QALY; Modeling; Budget Impact; Diagnostic; CMS; Centers for Medicare & Medicaid Services; CRP; C-reactive protein; FGID; functional gastrointestinal disorder; FODMAP; fermentable oligo-, di-, mono-saccharides, and polyols; IBD; inflammatory bowel disease;
Keywords: Wounds; Surgical site infection; Negative pressure wound therapy; Caesarean section; Cost-effectiveness analysis; NHMRC; National Health and Medical Research Council; NPWT; Negative Pressure Wound Therapy; SSI; Surgical Site Infection; QALY; Quality-Adjus
Keywords: High dose influenza vaccine; Cost-effectiveness analysis; Influenza vaccination policy; SD-IIV3; standard-dose trivalent inactivated influenza vaccine; HD-IIV3; high-dose trivalent inactivated influenza vaccine; RIV; recombinant trivalent influenza vaccin
Keywords: QALY; quality of life; stated preference; utility;
Keywords: cost-effectiveness analysis; discount; guideline; productivity loss; QALY;
Keywords: Obsessive-compulsive disorder; Deep brain stimulation; Economic evaluation; Psychiatry; CBT; cognitive behavioral therapy; ICER; incremental cost-effectiveness ratio; IPG; implantable pulse generator; OCD; obsessive-compulsive disorder; QALY; Quality adju
Keywords: Prevención secundaria cardiovascular; Policomprimido; Adherencia; Coste-efectividad; Secondary cardiovascular prevention; Polypill; Adherence; Cost-effectiveness; ACEI; angiotensin-converting enzyme inhibitors; NNT; number of patients needed to treat; QA
Keywords: RVGE; Rotavirus gastroenteritis; KSA; Kingdom of Saudi Arabia; QALY; quality-adjusted life years; SAR; Saudi Arabian-Riyal; Rotavirus; Vaccination; Kingdom of Saudi Arabia; Cost-effectiveness; Budget impact; Modeling;
Keywords: CAD; coronary artery disease; CCTA; coronary computed tomographic angiography; ECHO; echocardiogram; ETT; exercise treadmill testing; ICA; invasive coronary angiography; ICER; incremental cost-effectiveness ratio; MPS; myocardial perfusion scintigraphy; S
Keywords: AMD; age-related macular degeneration; BRVO; branch retinal vein occlusion; CI; confidence interval; CRVO; central retinal vein occlusion; ETDRS; Early Treatment Diabetic Retinopathy Study; HRVO; hemiretinal vein occlusion; QALY; quality-adjusted life-yea
Keywords: Peanut oral immunotherapy; Cost-effectiveness analysis; FAQL-PF; Food Allergy Quality of Life-Parent Form; ICER; Incremental cost-effectiveness ratio; OIT; Oral immunotherapy; POIT; Peanut oral immunotherapy; QALY; Quality-adjusted life-year; QOL; Quality
Keywords: CAN$; Canadian dollars; CXL; collagen cross-linking; DALK; deep anterior lamellar keratoplasty; ICER; incremental cost-effectiveness ratio; PKP; penetrating keratoplasty; QALY; quality-adjusted life year;
Keywords: BE; Barrett's esophagus; CISNET; Cancer Intervention and Surveillance Modeling Network; EAC; esophageal adenocarcinoma; HGD; high-grade dysplasia; LGD; low-grade dysplasia; NCI; National Cancer Institute; NNT/death; number of treatments needed to preven
Keywords: DALY; Disability-Adjusted Life Year; FAO; Food and Agriculture Organization of the United Nations; GBD; Global Burden of Disease; MCDA; Multi-Criteria Decision Analysis; QALY; Quality-Adjusted Life Year; SMPH; Summary Measure of Population Health; WHO; Wo
Keywords: Vaccination; Health economics; QALY; Damped oscillations;
Keywords: Cancer Detection; Screening; Population; Tumorigenesis; BE; Barrett's esophagus; EAC; esophageal adenocarcinoma; GEJ; gastroesophageal junction; HGD; high-grade dysplasia; H2RA; histamine receptor antagonist; IM; intestinal metaplasia; LGD; low-grade dy
Keywords: cost-effectiveness; mediastinal lymph node staging; EBUS-TBNA; mediastinoscopy; CAD; Canadian dollar; CRMM; cancer risk management model; EBUS-TBNA; endobronchial ultrasound transbronchial needle aspiration; ICER; incremental cost effectiveness ratio; LN;
Keywords: Cost Effectiveness; Budget Impact; Public Health; Health Care Expenses; CEA; cost-effectiveness analysis; CHEERS; The Consolidated Health Economic Evaluation Reporting Standards; DAA; direct-acting antiviral; HCV; hepatitis C virus; ICER; incremental cost
Keywords: EE; economic evaluation; OECD; Organization for Economic Co-operation and Development; CEA; cost-effectiveness analysis; CER; cost-effectiveness ratio; ICER; incremental cost-effectiveness ratio; WTP; willingness to pay; NICE; National Institute for Healt
Keywords: EQ-5D; EuroQol-5 Dimension; ICER; incremental cost-effectiveness ratio; QALY; quality-adjusted life year; QOL; quality of life; SF-36; Short-Form 36; VM; venous malformation;
Keywords: GAVI; the Global Vaccine Alliance; GDP; gross domestic product; HBV; hepatitis B virus; Hib; Haemophilus influenzae type b; HPV; human papillomavirus; IQ; intelligence quotient; OPV; oral polio vaccine; QALY; quality adjusted life year; UMV; universal mas
Keywords: urology; venous thrombosis; pulmonary embolism; cost-benefit analysis; prevention & control; ACCP; American College of Chest Physicians; ASCO; American Society of Clinical Oncology; DVT; deep vein thrombosis; EDP; extended duration prophylaxis; ICER; incr
Keywords: ICER; incremental cost-effectiveness ratio; QALY; quality-adjusted life-year; ITC; indirect treatment comparison; Chronic lymphocytic leukaemia; Obinutuzumab; Chlorambucil; Rituximab; Ofatumumab; Cost-effectiveness; Costs;
Keywords: Cervical; Cost; Cost-effectiveness; Decompression; Fusion; QALY; Spine;
Keywords: B41; D61; D81; I18; Cold pressor test; Utility function over pain; QALY; Real consequences;
Keywords: menopause; Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE); preference; QALY; quality-adjusted life-year; symptoms; women's health;
Keywords: Pap; Papanicolaou; HR; high-risk; HPV; human papillomavirus; LR; low risk; PHU; public health unit; MOHLTC; Ontario Ministry of Health and Long-Term Care; QALY; quality-adjusted life years; HSIL; high-grade cervical squamous intraepithelial lesion; CIN; c